Skip to Content

Join the 'Reversal of Nondepolarizing Muscle Relaxants' group to help and get support from people like you.

Reversal of Nondepolarizing Muscle Relaxants News

FDA Approves Bridion (sugammadex) to Reverse Effects of Neuromuscular Blocking Drugs

Posted 17 Dec 2015 by Drugs.com

December 15, 2015 – The U.S. Food and Drug Administration today approved Bridion (sugammadex) injection to reverse the effects of neuromuscular blockade induced by rocuronium bromide and vecuronium bromide, which are used during certain types of surgery in adults. Rocuronium bromide and vecuronium bromide are neuromuscular blocking drugs that cause temporary paralysis by interfering with the ...

Bridion Approved to Reverse Effects of Surgical Drugs

Posted 16 Dec 2015 by Drugs.com

TUESDAY, Dec. 15, 2015 – Bridion (sugammadex) has been approved by the U.S. Food and Drug Administration to reverse the effects of medications that are used to paralyze the vocal chords during certain surgical procedures. Rocuronium bromide and vecuronium bromide are prescribed when surgeons use an artificial airway or breathing tube, a process called tracheal intubation, the FDA said Tuesday in ...

Flamel Technologies Announces FDA Approval of Bloxiverz

Posted 5 Jun 2013 by Drugs.com

LYON, FRANCE – (Marketwire) – 06/03/2013 – Flamel Technologies today announced that the U.S. Food and Drug Administration (FDA) has approved the company's New Drug Application (NDA) for Bloxiverz (neostigmine methylsulfate), a drug used intravenously in the operating room for the reversal of the effects of non-depolarizing neuromuscular blocking agents after surgery. Flamel expects to launch ...

Ask a Question

Further Information

Related Condition Support Groups

Anesthesia

Related Drug Support Groups

Mestinon, pyridostigmine, neostigmine, Regonol, Mestinon Timespan, atropine / edrophonium, edrophonium, sugammadex, Enlon, Reversol, Tensilon, Enlon-Plus, Bridion